- Home
- PRQR vs POLE Comparison
PRQR vs POLE Comparison
Compare PRQR & POLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- POLE
- Stock Information
- Founded
- PRQR 2012
- POLE 2024
- Country
- PRQR Netherlands
- POLE United States
- Employees
- PRQR N/A
- POLE N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- POLE
- Sector
- PRQR Health Care
- POLE
- Exchange
- PRQR Nasdaq
- POLE NYSE
- Market Cap
- PRQR 309.5M
- POLE 294.2M
- IPO Year
- PRQR 2014
- POLE 2024
- Fundamental
- Price
- PRQR $2.67
- POLE $9.98
- Analyst Decision
- PRQR Strong Buy
- POLE
- Analyst Count
- PRQR 5
- POLE 0
- Target Price
- PRQR $7.60
- POLE N/A
- AVG Volume (30 Days)
- PRQR 603.0K
- POLE 16.1K
- Earning Date
- PRQR 11-07-2024
- POLE 01-01-0001
- Dividend Yield
- PRQR N/A
- POLE N/A
- EPS Growth
- PRQR N/A
- POLE N/A
- EPS
- PRQR N/A
- POLE N/A
- Revenue
- PRQR $20,506,357.00
- POLE N/A
- Revenue This Year
- PRQR $235.11
- POLE N/A
- Revenue Next Year
- PRQR N/A
- POLE N/A
- P/E Ratio
- PRQR N/A
- POLE N/A
- Revenue Growth
- PRQR 306.68
- POLE N/A
- 52 Week Low
- PRQR $1.61
- POLE $9.94
- 52 Week High
- PRQR $4.62
- POLE $11.16
- Technical
- Relative Strength Index (RSI)
- PRQR 38.02
- POLE N/A
- Support Level
- PRQR $2.48
- POLE N/A
- Resistance Level
- PRQR $2.71
- POLE N/A
- Average True Range (ATR)
- PRQR 0.29
- POLE 0.00
- MACD
- PRQR -0.08
- POLE 0.00
- Stochastic Oscillator
- PRQR 28.09
- POLE 0.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About POLE ANDRETTI ACQUISITION CORP. II
Andretti Acquisition Corp II is a blank check company.